In this study, the number of CD4+ and CD8+ T cells in the liver and spleen significantly decreased in the CLM group compared with those in the normal group, which showed that the cellular immunity of the liver and spleen decreased during the development of liver metastases from colon cancers. The gene discussed is CD8A; the disease is colonic neoplasm.